Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Rheumatology
Volume 2015 (2015), Article ID 614504, 3 pages
http://dx.doi.org/10.1155/2015/614504
Case Report

Lymphocutaneous Sporotrichosis during Treatment with Anti-TNF-Alpha Monotherapy

University “Magna Græcia” of Catanzaro, 88100 Catanzaro, Italy

Received 9 November 2014; Accepted 11 January 2015

Academic Editor: Shigeko Inokuma

Copyright © 2015 Francesco Ursini et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. B. D. L. Barros, R. de Almeida Paes, and A. O. Schubach, “Sporothrix schenckii and sporotrichosis,” Clinical Microbiology Reviews, vol. 24, no. 4, pp. 633–654, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. F. Barile, M. Mastrolonardo, F. Loconsole, and F. Rantuccio, “Cutaneous sporotrichosis in the period 1978–1992 in the province of Bari, Apulia, Southern Italy,” Mycoses, vol. 36, no. 5-6, pp. 181–185, 1993. View at Google Scholar · View at Scopus
  3. G. S. Gottlieb, C. F. Lesser, K. K. Holmes, and A. Wald, “Disseminated sporotrichosis associated with treatment with immunosuppressants and tumor necrosis factor-α antagonists,” Clinical Infectious Diseases, vol. 37, no. 6, pp. 838–840, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Yamaguchi, S. Ito, Y. Takano et al., “A case of disseminated sporotrichosis treated with prednisolone, immunosuppressants, and tocilizumab under the diagnosis of rheumatoid arthritis,” Internal Medicine, vol. 51, no. 15, pp. 2035–2039, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. K. L. Winthrop, E. Chang, S. Yamashita, M. F. Iademarco, and P. A. LoBue, “Nontuberculous mycobacteria infections and anti-tumor necrosis factor-alpha therapy,” Emerging Infectious Diseases, vol. 15, no. 10, pp. 1556–1561, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. J. P. Horcajada, J. L. Peña, V. M. Martínez-Taboada et al., “Invasive cryptococcosis and adalimumab treatment,” Emerging Infectious Diseases, vol. 13, no. 6, pp. 953–955, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. K. L. Winthrop, “Risk and prevention of tuberculosis and other serious opportunistic infections associated with the inhibition of tumor necrosis factor,” Nature Clinical Practice Rheumatology, vol. 2, no. 11, pp. 602–610, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Tsiodras, G. Samonis, D. T. Boumpas, and D. P. Kontoyiannis, “Fungal infections complicating tumor necrosis factor α blockade therapy,” Mayo Clinic Proceedings, vol. 83, no. 2, pp. 181–194, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. R. S. Wallis, M. S. Broder, J. Y. Wong, M. E. Hanson, and D. O. Beenhouwer, “Granulomatous infectious diseases associated with tumor necrosis factor antagonists,” Clinical Infectious Diseases, vol. 38, no. 9, pp. 1261–1265, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. W. G. Dixon, K. Watson, M. Lunt, K. L. Hyrich, A. J. Silman, and D. P. M. Symmons, “Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register,” Arthritis and Rheumatism, vol. 54, no. 8, pp. 2368–2376, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Listing, A. Strangfeld, S. Kary et al., “Infections in patients with rheumatoid arthritis treated with biologic agents,” Arthritis and Rheumatism, vol. 52, no. 11, pp. 3403–3412, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. I. Z. Carlos, M. M. C. Zini, D. B. D. G. da Graca Sgarbi, J. Angluster, C. S. Alviano, and C. L. Silva, “Disturbances in the production of interleukin-1 tumor and necrosis factor in disseminated murine sporotrichosis,” Mycopathologia, vol. 127, no. 3, pp. 189–194, 1994. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Tachibana, T. Matsuyama, and M. Mitsuyama, “Involvement of CD4+ T cells and macrophages in acquired protection against infection with Sporothrix schenckii in mice,” Medical Mycology, vol. 37, no. 6, pp. 397–404, 1999. View at Google Scholar · View at Scopus
  14. T. D. C. Negrini, L. S. Ferreira, P. Alegranci et al., “Role of TLR-2 and fungal surface antigens on innate immune response against Sporothrix schenckii,” Immunological Investigations, vol. 42, no. 1, pp. 36–48, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. D. de Lima Franco, R. C. Nascimento, K. S. Ferreira, and S. R. Almeida, “Antibodies against Sporothrix schenckii enhance TNF-α production and killing by macrophages,” Scandinavian Journal of Immunology, vol. 75, no. 2, pp. 142–146, 2012. View at Publisher · View at Google Scholar · View at Scopus